NCT07081282 Precision Stratification for Frailty and Cognitive Decline
| NCT ID | NCT07081282 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National University of Singapore |
| Condition | Frailty |
| Study Type | INTERVENTIONAL |
| Enrollment | 252 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 252 participants in total. It began in 2025-07-01 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Care4Senior mobile Application, Intensive Aerobic Resistance Training and Brain Health (CIRTAB) trial aim to test the effectiveness of an exercise, cognitive and lifestyle intervention amongst older adults over a 12-weeks trial period to prevent frailty and promote social bonding.
Eligibility Criteria
Inclusion Criteria: 1. Older Adults Aged 60 to 85 years old 2. Living in the community 3. Formally diagnosed with at least one chronic disease 4. Able to communicate in either English or Mandarin Exclusion Criteria: 1. Severe vision or hearing impairment 2. Diagnosed with severe cognitive impairment (e.g. dementia) 3. Diagnosed with severe psychiatric disorders (e.g. psychotic disorders, major depressive disorder)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07081282 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 85 Years, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07081282 currently recruiting?
Yes, NCT07081282 is actively recruiting participants. Contact the research team at vivien.wu@nus.edu.sg for enrollment information.
Where is the NCT07081282 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT07081282 clinical trial?
NCT07081282 is sponsored by National University of Singapore. The trial plans to enroll 252 participants.